Eli Lilly (LLY) GLP-1 Pill Approved: Launching Foundayo for Weight Loss
Published on Β· Source: cnbc.com
AI Summary
Summarized by AI from the source belowEli Lilly's (LLY) GLP-1 pill, Foundayo, has received FDA approval and will begin shipping via LillyDirect, available in pharmacies
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Eli Lilly and Company (LLY)
Eli Lilly is a major pharmaceutical company known for diabetes and obesity treatments and a broad drug pipeline.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier LLY news
- Lilly (LLY) Wins FDA Approval for Oral Obesity Drug Foundayo
- Eli Lilly (LLY) stock surges after FDA obesity pill approval
- Lilly (LLY) to Acquire Centessa for OX2R Sleep Disorders
- Stocks Soar on Hopes of Iran War Resolution Amid Market Optimism
- Centessa (CNTA) Downgraded After Lilly Deal Announcement
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
